What YD Diagnostics does

YD Diagnostics is a South Korean privately-held in vitro diagnostic (IVD) medical device manufacturer operating for over 40 years. It sells a diversified diagnostic product portfolio organized into six proprietary lines: URiSCAN urine analysis (strips, chemistry analyzers, the PluScope sediment analyzer with microscopic imaging, and quality controls); MolecuTech molecular diagnostics (real-time PCR assays for tuberculosis, HPV, COVID-19, and sexually transmitted infections); ImmunTech rapid immunochromatographic tests (tumor markers, cardiac markers, and fecal occult blood); EASYPREP liquid-based cytology systems; AceChemStain histology and cytology staining reagents; and clinical chemistry reagents. The portfolio spans screening, confirmatory, and monitoring use cases across hospital laboratories, public-health programs, and small-to-mid clinical labs.

The underlying technology is conventional IVD: reflectance photometry and automated microscopy for urine, real-time PCR for molecular targets, lateral-flow immunochromatography for rapid tests, and liquid-based cytology preparation for cell morphology. The PluScope analyzer is the most technologically differentiated instrument, applying multi depth-of-field fusion imaging to urinary sediment particles. Products are cleared by KFDA, hold FDA 510(k) and CE markings where applicable, and are manufactured in Korea.

The business model is B2B export-led: YD Diagnostics sells through international distributors to 116+ countries, with no direct enterprise accounts or framework contracts disclosed. Revenue is generated through instrument placement (urine chemistry analyzers, PluScope, EASYPREP processors) paired with high-margin recurring consumables (strips, PCR reagents, rapid test cassettes, QC materials, staining reagents), creating a razor-and-blade economics for the installed base. No revenue, headcount, funding, or M&A history is publicly disclosed, consistent with its privately-held status.

Name

YD Diagnostics

Legal name

YD Diagnostics

Website

https://yd-diagnostics.com

Company type

Private

Founded year

1966

Operating status

Operating

Headcount range

51–100 employees

Short description

YD Diagnostics is a privately-held South Korean in vitro diagnostics manufacturer selling urine, molecular, rapid, and cytology testing products through international distributors to 116+ countries.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516), Medical Equipment and Supplies Manufacturing (3391)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Surgical & Medical Instruments & Apparatus (3841), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Multiplex & High-Throughput Diagnostics Platforms (microarrays, digital PCR, lab automation-enabled assays) (HLAAALAL), Quality Control, Calibrators, Standards & Proficiency Testing (IVD Consumables) (HLAHAAAL)

Keywords

• In vitro diagnostics
• Urine analyzers
• Molecular diagnostics
• Clinical chemistry reagents
• Cytology preparation systems

Headquarters

HQ city

Yongin

HQ country

South Korea

HQ region

Asia

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Technology or R&D, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Instruments and Analyzers: Sale of benchtop and floor-standing diagnostic analyzers including urine chemistry analyzers (URiSCAN Optima, Pro, Super+), urine sediment analyzers (PluScope), and nucleic acid extraction systems (DX32). Instruments provide recurring reagent/consumable revenue.
2. Reagents and Consumables: Recurring revenue from test strips, cassettes, reagents, control materials, and consumables for diagnostic instruments. Includes URiSCAN urine strips (various configurations), PCR assay kits, clinical chemistry reagents, and cytology supplies.
3. Quality Control Products: URiTROL liquid and lyophilized urinalysis control products for quality assurance in laboratories.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels2 records

Core offering

YD Diagnostics manufactures and sells in vitro diagnostic instruments, reagents, and consumables used by clinical laboratories and hospitals. The portfolio spans automated urine chemistry and sediment analyzers (URiSCAN product family), PCR-based molecular diagnostic assays for infectious diseases (MolecuTech), rapid immunochromatographic tests for cardiac and tumor markers (ImmunTech), liquid-based cytology slide preparation systems (EASYPREP), and laboratory staining reagents (AceChemStain). Instrument placements drive recurring revenue from associated reagent kits and consumables.

Product overview

YD Diagnostics is a medical diagnostics company offering a diversified portfolio of in vitro diagnostic products across multiple technology platforms. The product portfolio comprises five main brands: URiSCAN (urine analysis systems with reagent strips, automated chemistry and sediment analyzers, and quality controls), MolecuTech (molecular diagnostics for PCR-based detection of tuberculosis, HPV, COVID-19, and STIs with supporting instruments like HybREAD480 and DX32), ImmunTech (rapid immunochromatographic tests for tumor markers, cardiac markers, and fecal occult blood), EASYPREP (liquid-based cytology slide preparation system with reagents and consumables), and AceChemStain (histological staining reagents for cytology and microbiology). The company also offers clinical chemistry reagents for automated analyzers. YD Diagnostics serves clinical laboratories worldwide with products validated across 116 countries and regulatory approvals including FDA, CE, and KFDA.

Differentiator

Problem solved

Functional benefit

Brands

• URiSCAN: Urine chemistry analyzers and test strips for urinalysis including URiSCAN Optima, PRO, Super+, and PluScope automated urine sediment analyzer.
• MolecuTech
• ImmunTech
• EASYPREP
• AceChemStain

Products and services

• URiSCAN Urine Reagent Strips Urine reagent test strips supporting 1-14 parameters including Blood, Bilirubin, Urobilinogen, Ketones, Protein, Nitrite, Glucose, pH, Specific Gravity, Leucocytes, Ascorbic Acid, Microalbumin, and Creatinine, with FDA 510(k) and CE approvals for professional use and self-test.
• URiSCAN Optima Semi-Automatic Urine Analyzer Semi-automatic urine chemistry analyzer with CCD color image sensor, 4.3-inch touch screen TFT LCD, 2,000 test result memory, and throughput of 100 tests per hour (6 seconds in quick mode). Designed for clinical laboratories.
• URiSCAN PRO Semi-Automatic Urine Analyzer Semi-automatic urine analyzer with 7-inch touch screen, 720 tests per hour throughput, closed system for URiSCAN strips, automatic urine color adjustment, and 3,000 patient record memory for clinical laboratory use.
• URiSCAN Super+ Fully Automated Urine Chemistry Analyzer Fully automated urine chemistry analyzer supporting up to 15 parameters with unique 400-test strip loading capacity and 200 tests/hour throughput. Operates standalone or integrated with URiSCAN PluScope, with KFDA approval.
• URiSCAN PluScope Automated Urine Sediment Analyzer High-end fully automated urine sediment analyzer using microscopic imaging analysis with multi-depth field fusion, providing 18 reportable parameters including RBC, WBC, bacteria, crystals, and casts at 120 tests per hour. KFDA approved.
• URiTROL Urinalysis Quality Control Assayed quality control urine material for monitoring accuracy and precision of URiSCAN urine strips and analyzers, available in liquid ready-to-use and lyophilized formats for laboratory quality assurance programs.
• MolecuTech TB Detection Assays PCR-based assay systems for detection and differentiation of Mycobacterium tuberculosis (MTB) including TB-Tag Two (nested PCR), MTB-ID V3 (MTB/NTM differentiation), Real TB-Tag (real-time PCR), and REBA assays for MDR/XDR drug resistance profiling.
• MolecuTech HPV Genotyping Assays REBA HPV-ID reverse blot hybridization assay identifying 32 HPV genotypes (18 high-risk, 1 medium-risk, 13 low-risk) and Real HPV 16/18/HR real-time PCR assay for HPV 16, 18, and 12 high-risk types for cervical cancer screening.
• MolecuTech STI and COVID-19 Real-Time PCR Assays Real-time PCR assays for detection of Chlamydia trachomatis and Neisseria gonorrhoeae (Real CT/NG), Herpes Simplex Virus types 1 and 2 (Real HSV 1/2), and SARS-CoV-2 plus pan-coronavirus detection (Real-Time COVID-19) with 2-hour turnaround.
• HybREAD480 Automated REBA Processor Fully automated strip assay processor handling sample preparation through result interpretation for REBA assays, with capacity for 48 samples, CMOS camera detection, and built-in UV lamp for contamination prevention.
• DX32 Automated Nucleic Acid Purification System Automated nucleic acid extraction platform using Magnetic Pillar technology, processing up to 32 samples in 40 minutes with built-in UV decontamination, paired with extraction kits for viral DNA/RNA, bacterial, whole blood, and tissue genomic DNA.
• ImmunTech Rapid Immunoassays (Cardiac and Tumor Markers) Rapid immunochromatographic cassette tests including OcculTech FOB (fecal occult blood, 100% sensitivity, 98.9% specificity), AFP (tumor marker), CEA (tumor marker), PSA (prostate-specific antigen), and Cardiac Triple Test (Troponin I, CK-MB, Myoglobin) with 5-15 minute results.
• Clinical Chemistry Reagents Reagents for automated clinical chemistry analyzers including assays for AST, ALT, Glucose, ALP, Amylase, Creatinine, Uric Acid, Cholesterol, HDL-C, LDL-C, Calcium, Bilirubin, Total Protein, Albumin, Phosphorus, Triglycerides, gamma-GT, BUN, LDH, CK-NAC, and Hemoglobin, plus lipid profile reagents.
• EASYPREP Liquid-Based Cytology System Automated liquid-based cytology processor using sedimentation and centrifuge method with built-in centrifuge, 56 tests per hour throughput, KFDA and CE certified, paired with methanol/isopropanol-free preservative solution and reagent kits for cervical and non-gynecologic specimens.
• AceChemStain Laboratory Staining Reagents Laboratory staining reagents for cytology and microbiology including Papanicolaou Stain (Harris Hematoxylin and Gill's-II variants), AFB Stain (Ziehl-Neelsen method), Gram Stain (gram-positive/negative differentiation), and Wright Stain (differential blood cell count).

Quantifiable outcome

• URiSCAN Super+ achieves 200 tests/hour throughput with 400-sample strip loading capacity
• +3 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration5 records

Feature6 records

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Broad incumbents

• Hologic: Women's health and molecular diagnostics specialist with ThinPrep liquid-based cytology, Panther molecular systems, and Aptima HPV/STI assays. Competes with YD's EASYPREP cytology and MolecuTech HPV/CT/NG portfolios.
• Beckman Coulter Diagnostics: Large IVD incumbent offering urine chemistry analyzers, clinical chemistry, and immunoassay reagents globally. Competes with YD's clinical chemistry reagents and URiSCAN line in routine and reference laboratories.
• Roche Diagnostics: World's largest IVD player with cobas analyzers, urine screening strips, and molecular diagnostics (including TB and HPV). Overlaps with nearly all of YD's product families as a broad portfolio incumbent.
• Siemens Healthineers: Major IVD vendor with ADVIA Centaur and Atellica clinical chemistry/immunoassay analyzers plus urine analysis reagents. Competes with YD in clinical chemistry, immunoassays, and routine urine workflows.

Direct peers

• Sysmex: Global leader in urinalysis (UF-series) and hematology analyzers with proprietary urine sediment analysis. Direct competitor to YD's URiSCAN PluScope and Super+ in mid- and high-throughput clinical labs worldwide.
• Cepheid (Danaher): Leader in automated molecular diagnostics with GeneXpert systems for TB (Xpert MTB/RIF), CT/NG, HPV, and COVID-19. Direct competitor to YD's MolecuTech molecular assays in the same disease areas.
• Mindray: Chinese IVD manufacturer with broad urinalysis, clinical chemistry, and hematology analyzer lines plus reagent strips. Competes head-to-head with YD in emerging markets and on price-sensitive hospital tenders.
• Seegene: Korean molecular diagnostics company specializing in multiplex PCR assays for infectious diseases, including TB, HPV, CT/NG, and COVID-19. Closest direct Korean peer to YD's MolecuTech PCR/REBA product line.

Emerging players

• Erba Mannheim: Mid-tier global IVD manufacturer offering clinical chemistry, urine chemistry analyzers, and hematology systems targeted at emerging markets. Comparable mid-tier positioning to YD with overlapping urinalysis and chemistry product lines.

Regional players

• SD Biosensor: Korean IVD company focused on rapid immunochromatographic tests (cardiac, tumor, infectious disease markers) and hemoglobin analyzers. Closest Korean peer to YD's ImmunTech rapid immunoassay line.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about YD Diagnostics